Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034458926> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2034458926 endingPage "163" @default.
- W2034458926 startingPage "151" @default.
- W2034458926 abstract "A central finding of the UKPDS was that in type 2 diabetic patients, tight glycemic control with HbA1c targets as close to the normal range as possible must be achieved to further reduce diabetes related-complications, -mortality, and -cardiovascular disease, highlighting the need for new, optimized treatment strategies. With a focus on clinical efficacy, this paper discusses the results from the 20 major therapeutical trials published in the years 1997-1999, that evaluated the new insulinsensitizing thiazolidinediones Rosiglitazone and Pioglitazone and the new insulin-releasing potassium channel blockers Repaglinide and Nateglinide. While for Nateglinide, promising, but only preliminary data is available at current, Rosiglitazone, Pioglitazone, and Repaglinide have been shown appropriate for both mono- and combination therapy with current standard drug treatment of type 2 diabetes. Similar to the known, older antidiabetic drugs, the new agents discussed have comparable blood glucose lowering potentials with a dose-related capacity of 0.5 to 1.5% HbA1c reduction. These beneficial effects were both seen in drug-naive patients previously treated with diet only and in combination therapies where patients had previous antidiabetic standard drug treatment suggesting effectiveness of glitazones and glinides also in more advanced stages of the disease. Problems with adverse effects appeared minor although longe-range implications of weight gain, edema, lowering of hemoglobin, increase of total cholesterol for the glitazones, and hypoglycemia for glinides warrant further consideration. What becomes clear from the variety of most recent mono- and combination treatment studies with as much as five different classes of antidiabetic drugs is that individually tailored therapies that recognize quality of life parameters and target the predominant features of metabolic pathology (such as early postprandial versus fasting hyperglycemia, degree of insulin resistance, progressive loss of β-cell function) may become a feasible goal in the future." @default.
- W2034458926 created "2016-06-24" @default.
- W2034458926 creator A5022638331 @default.
- W2034458926 creator A5036967075 @default.
- W2034458926 creator A5090174827 @default.
- W2034458926 date "2000-12-31" @default.
- W2034458926 modified "2023-10-03" @default.
- W2034458926 title "Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus" @default.
- W2034458926 doi "https://doi.org/10.1055/s-2000-7737" @default.
- W2034458926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10926309" @default.
- W2034458926 hasPublicationYear "2000" @default.
- W2034458926 type Work @default.
- W2034458926 sameAs 2034458926 @default.
- W2034458926 citedByCount "82" @default.
- W2034458926 countsByYear W20344589262012 @default.
- W2034458926 countsByYear W20344589262013 @default.
- W2034458926 countsByYear W20344589262014 @default.
- W2034458926 countsByYear W20344589262015 @default.
- W2034458926 countsByYear W20344589262017 @default.
- W2034458926 countsByYear W20344589262018 @default.
- W2034458926 countsByYear W20344589262019 @default.
- W2034458926 countsByYear W20344589262020 @default.
- W2034458926 countsByYear W20344589262021 @default.
- W2034458926 countsByYear W20344589262022 @default.
- W2034458926 crossrefType "journal-article" @default.
- W2034458926 hasAuthorship W2034458926A5022638331 @default.
- W2034458926 hasAuthorship W2034458926A5036967075 @default.
- W2034458926 hasAuthorship W2034458926A5090174827 @default.
- W2034458926 hasConcept C126322002 @default.
- W2034458926 hasConcept C134018914 @default.
- W2034458926 hasConcept C2777180221 @default.
- W2034458926 hasConcept C2778384471 @default.
- W2034458926 hasConcept C2778848681 @default.
- W2034458926 hasConcept C2779463123 @default.
- W2034458926 hasConcept C2780152017 @default.
- W2034458926 hasConcept C2780473172 @default.
- W2034458926 hasConcept C2780668416 @default.
- W2034458926 hasConcept C2781281211 @default.
- W2034458926 hasConcept C2910068830 @default.
- W2034458926 hasConcept C555293320 @default.
- W2034458926 hasConcept C71924100 @default.
- W2034458926 hasConcept C98274493 @default.
- W2034458926 hasConceptScore W2034458926C126322002 @default.
- W2034458926 hasConceptScore W2034458926C134018914 @default.
- W2034458926 hasConceptScore W2034458926C2777180221 @default.
- W2034458926 hasConceptScore W2034458926C2778384471 @default.
- W2034458926 hasConceptScore W2034458926C2778848681 @default.
- W2034458926 hasConceptScore W2034458926C2779463123 @default.
- W2034458926 hasConceptScore W2034458926C2780152017 @default.
- W2034458926 hasConceptScore W2034458926C2780473172 @default.
- W2034458926 hasConceptScore W2034458926C2780668416 @default.
- W2034458926 hasConceptScore W2034458926C2781281211 @default.
- W2034458926 hasConceptScore W2034458926C2910068830 @default.
- W2034458926 hasConceptScore W2034458926C555293320 @default.
- W2034458926 hasConceptScore W2034458926C71924100 @default.
- W2034458926 hasConceptScore W2034458926C98274493 @default.
- W2034458926 hasIssue "03" @default.
- W2034458926 hasLocation W20344589261 @default.
- W2034458926 hasLocation W20344589262 @default.
- W2034458926 hasOpenAccess W2034458926 @default.
- W2034458926 hasPrimaryLocation W20344589261 @default.
- W2034458926 hasRelatedWork W1998369233 @default.
- W2034458926 hasRelatedWork W2013113791 @default.
- W2034458926 hasRelatedWork W2034458926 @default.
- W2034458926 hasRelatedWork W2084097844 @default.
- W2034458926 hasRelatedWork W2101946628 @default.
- W2034458926 hasRelatedWork W2234493322 @default.
- W2034458926 hasRelatedWork W2409472385 @default.
- W2034458926 hasRelatedWork W2767225912 @default.
- W2034458926 hasRelatedWork W2098133448 @default.
- W2034458926 hasRelatedWork W2288504006 @default.
- W2034458926 hasVolume "108" @default.
- W2034458926 isParatext "false" @default.
- W2034458926 isRetracted "false" @default.
- W2034458926 magId "2034458926" @default.
- W2034458926 workType "article" @default.